Find clinical trials for Adenocarcinoma in Ann Arbor, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Ann Arbor, MI, USA:

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of ...

Active, not recruiting
Esophageal Adenocarcinoma
Drug: Carboplatin
Drug: Pembrolizumab

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

Ann Arbor, Michigan, United States and 3 other locations

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3


Detroit, Michigan, United States and 197 other locations

and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has not progressed on a first line fluoropy...

Metastatic Pancreatic Adenocarcinoma
Drug: Capecitabine
Drug: Ivaltinostat

Phase 1, Phase 2

CG Pharmaceuticals

Detroit, Michigan, United States of America and 19 other locations

The purpose of this study is to determine the Objective Response Rate (ORR) of zolbetuzimab as a single agent as assessed by an independent central r...

Pharmacokinetics of Oxaliplatin
Pharmacokinetics of Zolbetuximab
Drug: folinic acid
Drug: fluorouracil

Phase 2


Detroit, Michigan, United States and 25 other locations

The aim of this study is to characterize the safety and tolerability of MORAb-202, and to assess the objective response rate in participants with pre...

Carcinoma, Non-Small-Cell Lung
Drug: MORAb-202

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Detroit, Michigan, United States and 32 other locations

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Detroit, Michigan, United States and 67 other locations

Status recently updated

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Ann Arbor, Michigan, United States and 212 other locations

The goal of this clinical trial is to test an experimental treatment (immunotherapy) in pancreatic cancer patients. The main research objectives are:...

Pancreatic Ductal Adenocarcinoma
Drug: ATP150
Drug: Ezabenlimab

Phase 1

Amal Therapeutics

Detroit, Michigan, United States and 13 other locations

mCRPC. Patients enrolled in the Phase 2a portion of the study will have either Small Cell Neuroendocrine Prostate Cancer(SCNC)(Cohort A) or adenocarcinoma...

Active, not recruiting
Small Cell Carcinoma
Neuroendocrine Tumors
Drug: BXCL701 monotherapy
Drug: BXCL701 plus Pembrolizumab

Phase 1, Phase 2

BioXcel Therapeutics

Detroit, Michigan, United States and 11 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Apatinib
Drug: Ramucirumab+ paclitaxel

Phase 3


Ann Arbor, Michigan, United States and 149 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems